MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AdaptHealth Corp. Book Value 2011-2026 | AHCO
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value AdaptHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.53 B | 1.58 B | 1.47 B | 2.16 B | 2.07 B | 395 M | -29.2 M | 246 M | 24.3 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.16 B | -29.2 M | 1.05 B |
Quarterly Book Value AdaptHealth Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.62 B | 1.59 B | 1.57 B | 1.58 B | 1.52 B | 1.49 B | 1.47 B | 1.47 B | 1.74 B | 2.19 B | 2.17 B | 2.16 B | 2.16 B | 2.14 B | 2.12 B | 2.07 B | 1.99 B | 1.89 B | 1.79 B | 281 M | 281 M | 281 M | 281 M | -65.8 M | -29.2 M | -29.2 M | -29.2 M | 103 M | 246 M | 246 M | 246 M | 24.3 K | 24.3 K | 24.3 K | 24.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.19 B | -65.8 M | 1.04 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
EDAP TMS S.A.
EDAP
|
56.9 M | $ 3.45 | 1.77 % | $ 129 M |  France |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
3.85 B | $ 171.87 | 0.74 % | $ 12.9 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
129 M | $ 32.64 | -5.23 % | $ 1.5 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
169 M | $ 4.13 | 0.49 % | $ 874 M | USA |
 |
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
1.82 B | $ 36.74 | -0.05 % | $ 5.47 K | USA |
 |
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 62.59 | -0.37 % | $ 92.7 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 10.97 | 1.29 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
1.03 B | - | - | $ 1.06 B | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 9.38 | 0.11 % | $ 266 M | USA |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.59 | 1.2 % | $ 36.7 M | USA |
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 9.7 | 0.73 % | $ 347 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
10.3 B | $ 81.19 | 0.17 % | $ 47.5 B | USA |
 |
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
43.2 M | $ 23.61 | 1.37 % | $ 200 M | USA |
 |
FONAR Corporation
FONR
|
146 M | $ 18.6 | 0.05 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
4.57 B | $ 88.6 | 0.77 % | $ 12 B | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 1.9 | 2.15 % | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.55 B | $ 9.31 | -2.31 % | $ 717 M | USA |
 |
Inogen
INGN
|
192 M | $ 6.36 | 2.42 % | $ 169 M | USA |
 |
Inspire Medical Systems
INSP
|
781 M | $ 54.14 | -1.55 % | $ 1.59 B | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 1.0 | 1.66 % | $ 16.9 M | USA |
 |
IRadimed Corporation
IRMD
|
94.6 M | $ 95.66 | -0.59 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.75 B | $ 85.63 | -1.4 % | $ 2.97 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
GBS
GBS
|
2.81 M | - | -0.57 % | $ 7.12 M | USA |